Oxidative Stress — An Evaluation of Salivary Oxidant and Antioxidant Levels in Peri-implant Health and Disease
Citation(s)
Berglundh T, Persson L, Klinge B A systematic review of the incidence of biological and technical complications in implant dentistry reported in prospective longitudinal studies of at least 5 years. J Clin Periodontol. 2002;29 Suppl 3:197-212; discussion 232-3. doi: 10.1034/j.1600-051x.29.s3.12.x.
Canakci CF, Cicek Y, Canakci V Reactive oxygen species and human inflammatory periodontal diseases. Biochemistry (Mosc). 2005 Jun;70(6):619-28. doi: 10.1007/s10541-005-0161-9.
Chapple IL, Brock G, Eftimiadi C, Matthews JB Glutathione in gingival crevicular fluid and its relation to local antioxidant capacity in periodontal health and disease. Mol Pathol. 2002 Dec;55(6):367-73. doi: 10.1136/mp.55.6.367.
Chapple IL, Brock GR, Milward MR, Ling N, Matthews JB Compromised GCF total antioxidant capacity in periodontitis: cause or effect? J Clin Periodontol. 2007 Feb;34(2):103-10. doi: 10.1111/j.1600-051X.2006.01029.x. Epub 2006 Dec 13.
Chapple IL, Matthews JB The role of reactive oxygen and antioxidant species in periodontal tissue destruction. Periodontol 2000. 2007;43:160-232. doi: 10.1111/j.1600-0757.2006.00178.x. No abstract available.
Chapple IL Reactive oxygen species and antioxidants in inflammatory diseases. J Clin Periodontol. 1997 May;24(5):287-96. doi: 10.1111/j.1600-051x.1997.tb00760.x.
Chapple IL Role of free radicals and antioxidants in the pathogenesis of the inflammatory periodontal diseases. Clin Mol Pathol. 1996 Oct;49(5):M247-55. doi: 10.1136/mp.49.5.m247. No abstract available.
Edgar WM Saliva: its secretion, composition and functions. Br Dent J. 1992 Apr 25;172(8):305-12. doi: 10.1038/sj.bdj.4807861.
Erel O A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005 Dec;38(12):1103-11. doi: 10.1016/j.clinbiochem.2005.08.008. Epub 2005 Oct 7.
Erel O A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem. 2004 Apr;37(4):277-85. doi: 10.1016/j.clinbiochem.2003.11.015.
Guncu GN, Tozum TF, Guncu MB, Yamalik N, Tumer C, Karabulut E, Kilinc K Myeloperoxidase as a measure of polymorphonuclear leukocyte response in inflammatory status around immediately and delayed loaded dental implants: a randomized controlled clinical trial. Clin Implant Dent Relat Res. 2008 Mar;10(1):30-9. doi: 10.1111/j.1708-8208.2007.00058.x.
Guo M, Liu L, Zhang J, Liu M Role of Reactive Oxygen Species and Advanced Glycation End Products in the Malfunctioning of Dental Implants. West Indian Med J. 2015 Sep;64(4):419-23. doi: 10.7727/wimj.2014.105. Epub 2015 Apr 29.
Liskmann S, Zilmer M, Vihalemm T, Salum O, Fischer K Correlation of peri-implant health and myeloperoxidase levels: a cross-sectional clinical study. Clin Oral Implants Res. 2004 Oct;15(5):546-52. doi: 10.1111/j.1600-0501.2004.01061.x.
Liu Z, Liu Y, Song Y, Zhang X, Wang S, Wang Z Systemic oxidative stress biomarkers in chronic periodontitis: a meta-analysis. Dis Markers. 2014;2014:931083. doi: 10.1155/2014/931083. Epub 2014 Nov 16.
Misch CE Contemporary Implant Dentistry. 3 rd ed. St. Louis, Missouri, Mosby; 2008.
Mousavi Jazi M, Sadeghi Pour Rodsari HR, Mirmiran F Level of Oxidative Stress Markers in Peri-Implant Crevicular Fluid and Their Correlation with Clinical Parameters. J Dent (Tehran). 2015 May;12(5):340-6.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
